RNAZ - TransCode Therapeutics, Inc.

CVS
CVS Health Corporation
71.48
100 x 71.00
200 x 72.88
bid
ask
-
0.38
0.53%
150 @ 04:00 PM
71.96 +0.48 (0.67%)
Ytd -9.93%
1y 4.14%
70.21
day range
71.73
58.75
52 week range
83.87
Open 71.50 Prev Close 71.86 Low 70.21 High 71.73 Mkt Cap 90.94B
Vol 18.87M Avg Vol 8.34M EPS 1.38 P/E 51.80 Forward P/E 8.79
Beta 0.46 Short Ratio 1.67 Inst. Own 90.80% Dividend 2.66 Div Yield 3.64
Ex Div Date 01-22 Earning 05-06 50-d Avg 77.91 200-d Avg 74.04 1yr Est 96.50
Earning
Date For Estimate Reported Surprise surprise %
2026-05-07 2026-03 2.22 N/A N/A N/A
2026-02-10 2025-12 0.99 1.09 0.1 10.10%
2025-10-29 2025-09 1.36 1.6 0.24 17.65%
2025-07-31 2025-06 1.47 1.81 0.34 23.13%
2025-05-01 2025-03 1.71 2.25 0.54 31.58%
2025-02-12 2024-12 0.89 1.19 0.3 33.71%
Upgrade / Downgrade
Date Firm Action From To
2026-03-12 Bernstein Upgrade Market Perform Outperform
2026-01-28 Argus Research Upgrade Buy Buy
2026-01-27 B of A Securities Upgrade Buy Buy
2026-01-06 Bernstein Upgrade Market Perform Market Perform
2025-12-17 JP Morgan Upgrade Overweight Overweight
2025-12-12 Bernstein Upgrade Market Perform Market Perform
Profile
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Insider Holder
Date Name Relation Quantity Description
2025-11-19 AGUIRRE FERNANDO Director 40.95K Stock Award(Grant)
2025-11-19 BALSER JEFFREY R M.D., PH.D. Director 13.66K Stock Award(Grant)
2025-11-19 BROWN C DAVID II Director 127.77K Stock Award(Grant)
2025-05-29 COMPTON-PHILLIPS AMY Officer 53.09K Stock Award(Grant)
2025-11-19 FINUCANE ANNE A Director 591.00 Stock Award(Grant)
2025-11-19 KIRBY JOHN SCOTT Director 12.99K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Blackrock Inc. 120.99M 8.65B 9.51%
2025-12-30 Vanguard Group Inc 120.71M 8.63B 9.49%
2025-12-30 Capital World Investors 67.66M 4.84B 5.32%
2025-12-30 Dodge & Cox Inc. 62.51M 4.47B 4.91%
2025-12-30 State Street Corporation 60.18M 4.30B 4.73%
2025-12-30 FMR, LLC 41.02M 2.93B 3.22%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 Dodge & Cox Funds-Dodge & Cox Stock Fund 41.99M 3.00B 3.30%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 39.89M 2.85B 3.14%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 32.01M 2.29B 2.52%
2025-12-30 WASHINGTON MUTUAL INVESTORS FUND 30.67M 2.19B 2.41%
2025-12-30 Income Fund of America 23.69M 1.69B 1.86%
2025-12-30 AMERICAN BALANCED FUND 18.52M 1.32B 1.46%
Dividend
Dividend Date
0.665 2026-01-22
0.665 2025-10-23
0.665 2025-07-22
0.665 2025-04-22
0.665 2025-01-23
0.665 2024-10-21
Split
Split Date
2 : 1 2005-06-07
2 : 1 1998-06-16
2 : 1 1989-03-15
2 : 1 1983-05-03